Question 1

Does JPMorgan Chase own AVIR stock?

Accepted Answer

Yes. As of its Q2 2026 13F, JPMorgan Chase holds 945,918 shares of AVIR (Atea Pharmaceuticals), worth $4.4M.

Question 2

How many shares of AVIR does JPMorgan Chase own?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase holds 945,918 shares of AVIR (Atea Pharmaceuticals).

Question 3

What is JPMorgan Chase's AVIR position worth?

Accepted Answer

As of its Q2 2026 13F, JPMorgan Chase's AVIR position is worth $4.4M.

Question 4

Is JPMorgan Chase buying or selling AVIR?

Accepted Answer

In Q2 2026, JPMorgan Chase increased its AVIR position by 5,761 shares (+0.6%).

Question 5

When did JPMorgan Chase first buy AVIR?

Accepted Answer

JPMorgan Chase already held AVIR in its Q3 2024 13F, the earliest on record, and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	945,918	+0.6%	$4.4M	0.0%	$4.65	27
2026-Q1	Decreased	940,157	-30.3%	$4.8M	0.0%	$4.82	0
2025-Q4	Increased	1.3M	+118.6%	$4.8M	0.0%	$3.55	43
2025-Q3	Decreased	616,851	-5.5%	$1.8M	0.0%	$2.92	0
2025-Q2	Decreased	652,661	-15.6%	$2.3M	0.0%	$3.45	0
2025-Q1	Increased	773,217	+88.9%	$2.3M	0.0%	$2.93	41
2024-Q4	Increased	409,259	+329.7%	$1.4M	0.0%	$3.35	41
2024-Q3	First report	95,244	-	$319,067	0.0%	$3.35	0

AVIR8 quarters

AVIR
8 quarters